DJO Global, Inc., a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, announced that the first TaperFill™ Total Hip Replacement (THR) was implanted. TaperFill was developed to accommodate a minimally invasive procedure.
MedConnections Released PACE Health Connect App To Allow Patients To Manage Health Care Faster And EasierJuly 29, 2013 6:00 am | by PR Newswire | Comments
MedConnections launched its new mobile app, PACE Health Connect, featuring a patent pending interactive messaging system. Enterprise customers can provide employees, patients and members interactive messaging on 35 medical conditions with over 1,000 different messages, alerts and reminders to enhance their disease and lifestyle management.
Trovagene, Inc. (NASDAQ: TROV) and RainDance Technologies announced today that Trovagene has adopted RainDance's RainDropTM Digital PCR System for research and development, and for eventual use in the Trovagene CLIA laboratory. Trovagene has also announced successful development of a cell-free DNA mutation assay leveraging the RainDrop platform.
Public Workshop - The Patient Preference Initiative: Incorporating Patient Preference Information into the Medical Device Regulatory Processes, September 18-19, 2013July 29, 2013 12:00 am | by U.S. Food & Drug Administration | Comments
The purpose of this workshop is to discuss ways to incorporate patient preferences on the benefit-risk trade-offs of medical devices into the full spectrum of the Center for Devices and Radiological Heath (CDRH) regulatory decision making. It also aims...
Reason for Recall: GE Healthcare became aware of an incident at a VA Medical Center facility in the US. A patient died due to injuries sustained while being scanned on an Infinia Hawkeye 4 Nuclear Medicine System. On July 03, 2013 GE notified hospitals...
A prominent hacker who discovered a way to have automatic teller machines spit out cash and was set to deliver a talk about hacking pacemakers and other wireless implantable medical devices has died in San Francisco, authorities and his employer said.
Medicare Policies Restricting Power Wheelchair Repairs Leave Vulnerable Beneficiaries with Limited MobilityJuly 26, 2013 2:52 pm | by PR Newswire | Comments
For years, William Welch, 58, was a truck driver, a free spirit traveling along the roads. But now Welch spends his days in a Brunswick, Md. apartment, barely able to move from a chair to the refrigerator because his Medicare-supplied power wheelchair is broken and he can't find anyone to fix it, says the American Association for Homecare (AAHomecare).
DJO Global has announced the launch of the Empi Phoenix, an electrical stimulator designed to help simplify treatment of muscle atrophy before and after surgery for total knee replacement or ACL repair.
Zimmer settled a lawsuit with a prominent orthopedic surgeon who claimed a right to royalties for his work on some of the medical device company's knee implants, agreeing to dismiss the case with prejudice. Dr. Norman Scott sought to be included in a trio patents along with another physician, Dr. Giles Scuderi.
Minnesota medical devices maker EnteroMedics touted today that the FDA had accepted for review the company's premarket approval submission of the Maestro Rechargeable System's VBLOC implant, a neurostimulation device for treating obesity.
Princeton University researchers have created “souped up” versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.
Freiburg researchers develop hydrogels for tissue regeneration that can be fine-tuned to fit any body part. A new kind of gel that promotes the proper organization of human cells has been developed by Prof. Prasad Shastri of the Institute of Macromolecular Chemistry and BIOSS Centre for Biological Signalling Studies Excellence Cluster at the University of Freiburg.
Panasonic said Friday it will sell its ultrasonic diagnostic equipment business to Konica Minolta Inc. in January 2014 as part of efforts to improve its financial base eroded by the firm's recent sluggish performance.
Cepheid has announced that it has received market authorization from the U.S. Food & Drug Administration (FDA) for its Xpert MTB/RIF test. The review decision was based on the de novo 510(k) review process, which allows novel products without predicates to be down-classified and brought to market.
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.